Immunitrack
Business Services · Denmark · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Lersø Parkallé 42, København Ø, Capital ...Phone Number
+45 28682159Website
www.immunitrack.comRevenue
<$5 MillionIndustry
ZI Rank: 1
About Immunitrack
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Immunitrack your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Immunitrack has recently received funding, and reach out quickly before it becomes old news!
Click to see if Immunitrack had a recent Job posting/layoffs
Product Launch: Get notified when Immunitrack launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Immunitrack recently announced quarterly report
Immunitrack, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Immunitrack has new funding data
Check out if Immunitrack is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Immunitrack
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Immunitrack as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Immunitrack is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Immunitrack is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Immunitrack.
Immunitrack Tech Stack
A closer look at the technologies used by Immunitrack
Top Business Services Companies
Frequently Asked Questions Regarding Immunitrack
Immunitrack is founded upon world-leading academic research on MHC-epitope binding. Using our deep knowledge in this area, we have developed the proprietary epitope screening platform technology, NeoScreen®. NeoScreen® accurately assays the affinity and stability of MHC/epitope interactions, and the technology has the capacity to rapidly screen lib... Read More
